Coherus Oncology, Inc.CHRSNASDAQ
Loading
Operating Margin Over TimeContracting
Percentile Rank38
Studio
Year-over-Year Change

Operating income as a percentage of revenue

Percentile
P38
Within normal range
vs 5Y Ago
-13x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-425.72%-917.8%
2024-41.83%+47.0%
2023-78.99%+35.1%
2022-121.72%-50.6%
2021-80.80%-346.0%
202032.85%+8.5%
201930.27%+100.2%
2018-13137.28%+11.9%
2017-14918.77%-24364.1%
2016-60.98%-